Immunovant to Host Graves’ Disease Program Update on September 9, 2024
Investor webcast on Monday, September 9th at 8:00 a.m. ET NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Immunovant,Inc.(Nasdaq:IMVT), a clinical-stage immunology company dedicated to enabling normal l...